SCHEMBL968395

SCHEMBL968395

CS(=O)(=O)NC(=O)CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18778812 0.76 LDHA (0.42)
SCHEMBL3713808 0.76
SCHEMBL14178232 0.76 CA2 (0.38)
SCHEMBL92834 0.76
SCHEMBL18160817 0.75 EPHX2 (0.38)
SCHEMBL1385036 0.74
SCHEMBL19955899 0.74 CA2 (0.36)
SCHEMBL21872359 0.74 CA2 (0.36)
Hydrochloric Acid SCHEMBL5379762 0.74 MEN1 (0.39)
SCHEMBL7739122 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119320360-A In the selapage Process for the preparation of intermediates 重庆圣华曦药业股份有限公司 2025-01-17 CN disclosed
CN-109384734-B Preparation method of Selsemipa intermediate 上海科胜药物研发有限公司 2023-04-11 CN disclosed
CN-113214169-B Synthetic method of celecoxib intermediate 江苏海洋大学 2022-05-24 CN disclosed
CN-113214169-A Synthetic method of celecoxib intermediate 江苏海洋大学 2021-08-06 CN disclosed
CN-112939877-A Synthesis method of diphenylpyrazine derivative 南京理工大学 2021-06-11 CN disclosed
EP-3689855-A1 CRYSTALS Nippon Shinyaku Co., Ltd. (JP) 2020-08-05 EP disclosed
CN-107365275-B High purity celecoxib 杭州华东医药集团新药研究院有限公司 2020-07-03 CN disclosed
CN-109384733-B Method for preparing celecoxib intermediate compound in high yield under mild condition 新发药业有限公司 2020-04-28 CN disclosed
US-10544107-B2 Process for the preparation of 2-{4-[(5,6-diphenyl pyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide and novel polymorphs thereof MAITHRI DRUGS PRIVATE LIMITED (IN) 2020-01-28 US disclosed
US-10544107-B2 Process for the preparation of 2-{4-[(5,6-diphenyl pyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide and novel polymorphs thereof MAITHRI DRUGS PRIVATE LIMITED (IN) 2020-01-28 US disclosed
US-7867992-B2 such as 1-Cyclopropyl-N-(2,4-dichlorobenzyl)-6-fluoro-8-methoxy-7-[3-methyl-4-(2-{[(methylamino)carbonyl]amino}-2-oxoethyl)piperazin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxamide, used for the treatment and/or prophylaxis of viral diseases or infections, particularly against cytomegaloviruses AICURIS GMBH & CO. KG (DE) 2011-01-11 US disclosed
US-20070293478-A1 Substituted quinolones BAYER HEALTHCARE AG (DE) 2007-12-20 US disclosed
EP-1768973-B1 SUBSTITUTED QUINOLONES AICURIS GMBH & CO KG (DE) 2007-12-05 EP disclosed
EP-1768973-A1 SUBSTITUTED QUINOLONES AiCuris GmbH & Co. KG (DE) 2007-04-04 EP disclosed
WO-2006008046-A1 SUBSTITUTED QUINOLONES AICURIS GMBH & CO. KG (DE) 2006-01-26 WO disclosed
EP-0275804-B1 PROCESS FOR PREPARING PHOSPHORUS-CONTAINING INTERMEDIATES FOR HERBICIDAL USE RHONE-POULENC AGROCHIMIE (FR) 1991-10-02 EP disclosed
EP-0189725-B1 PREPARATION OF INTERMEDIATES CONTAINING PHOSPHORUS FOR HERBICIDAL USES RHONE-POULENC AGROCHIMIE (FR) 1989-03-08 EP disclosed
EP-0275804-A1 Process for preparing phosphorus-containing intermediates for herbicidal use RHONE-POULENC AGROCHIMIE (FR) 1988-07-27 EP disclosed
CN-87105951-A As herbicidal phosphorous intermediates preparation 1988-06-29 CN disclosed
EP-0189725-A1 Preparation of intermediates containing phosphorus for herbicidal uses RHONE-POULENC AGROCHIMIE (FR) 1986-08-06 EP disclosed